Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis

Background. Peroxisome proliferator-activated receptor-α (PPAR-α) is closely associated with the development of cardiac hypertrophy. Previous studies have indicated that bezafibrate (BZA), a PPAR-α agonist, could attenuate insulin resistance and obesity. This study was designed to determine whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Si-Chi, Ma, Zhen-Guo, Wei, Wen-Ying, Yuan, Yu-Pei, Tang, Qi-Zhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239981/
https://www.ncbi.nlm.nih.gov/pubmed/28127304
http://dx.doi.org/10.1155/2017/5789714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239981/
https://www.ncbi.nlm.nih.gov/pubmed/28127304
http://dx.doi.org/10.1155/2017/5789714

Ejemplares similares